Fortitude Family Office’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.8K Buy
108
+21
+24% +$7.79K 0.01% 323
2026
Q1
$25.5K Buy
87
+8
+10% +$2.63K 0.01% 378
2025
Q4
$27.7K Buy
79
+8
+11% +$2.7K 0.01% 337
2025
Q3
$22.9K Sell
71
-238
-77% -$74K 0.01% 365
2025
Q2
$120K Buy
309
+7
+2% +$2.82K 0.04% 154
2025
Q1
$131K Hold
302
0.05% 133
2024
Q4
$111K Sell
302
-452
-60% -$189K 0.04% 166
2024
Q3
$392K Buy
754
+6
+0.8% +$3.21K 0.16% 82
2024
Q2
$405K Buy
748
+715
+2,167% +$378K 0.23% 54
2024
Q1
$17.1K Buy
33
+1
+3% +$497 0.01% 304
2023
Q4
$15.1K Buy
+32
New +$14.8K 0.01% 344

Other funds holding ELV

Fortitude Family Office's ELV Position: Q2 2026 in Review

Fortitude Family Office increased its Elevance Health (ELV) stake by 24% in Q2 2026, buying an estimated $7.79K and bringing the position to 108 shares worth $41.8K. The position accounts for 0.01% of the portfolio, ranked #323.

Fortitude Family Office first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $405K in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fortitude Family Office held 108 shares of Elevance Health worth $41.8K as of Q2 2026.
  • Fortitude Family Office bought 21 Elevance Health shares in Q2 2026, an estimated $7.79K.
  • Elevance Health made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #323 holding.
  • Fortitude Family Office first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Elevance Health position peaked at $405K in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.